tradingkey.logo

Phibro Animal Health Corp

PAHC
查看详细走势图
40.060USD
+0.190+0.48%
收盘 01/15, 16:00美东报价延迟15分钟
1.62B总市值
23.94市盈率 TTM

Phibro Animal Health Corp

40.060
+0.190+0.48%
盘中分时
1分
30分
1小时
日k
周k
月k
日k

今天

+0.48%

5天

+0.86%

1月

-1.50%

6月

+31.09%

今年开始到现在

+7.23%

1年

+92.04%

查看详细走势图

TradingKey Phibro Animal Health Corp股票评分

单位: USD 更新时间: 2026-01-15

操作建议

Phibro Animal Health Corp当前公司基本面数据相对稳定,最新ESG披露属于行业中等水平。增长潜力很大。当前估值合理,在药品行业排名30/159位。机构持股占比非常高,近一月多位分析师给出公司评级为持有。最高目标价43.00。中期看,股价处于平稳状态。近一个月,市场表现一般,但公司基本面和技术面得分较高。目前股价在压力位和支撑位之间,可以做区间波段操作。

Phibro Animal Health Corp评分

相关信息

行业排名
30 / 159
全市场排名
103 / 4555
所属行业
药品

压力支撑

由于公司未披露,未能获取相关数据

多维评测

本期评分
上期评分

公司舆情

过去24小时
热度

过冷
过热
看好

Phibro Animal Health Corp亮点

亮点风险
Phibro Animal Health Corporation is a global diversified animal health and mineral nutrition company. It develops, manufactures and markets a range of products for food and companion animals, including poultry, swine, beef and dairy cattle, aquaculture and dogs. It markets approximately 750 product lines in over 80 countries to approximately 4,200 customers. It has three segments: Animal Health, Mineral Nutrition and Performance Products. Its Animal Health segment develops, manufactures and markets about 280 product lines, including antibacterials, anticoccidials and related products; nutritional specialty products; and vaccines. The Mineral Nutrition segment is comprised of formulations and concentrations of trace minerals such as zinc, manganese, copper, iron and other compounds, with a focus on customers in North America. The Performance Products segment manufactures and markets specialty ingredients for use in the personal care, industrial chemical and chemical catalyst industries.
业绩高增长
公司营业收入稳步增长,连续3年增长32.55%
利润高增长
公司净利润处于行业前列,最新年度总收入1.30B美元
高分红
公司属于高分红公司,最新股息支付率40.30%
稳定分红
公司5年内连续分红,最新股息支付率40.30%
估值合理
公司最新PE估值23.94,处于3年历史合理位
机构减仓
最新机构持股20.39M股,环比减少13.27%
查克·罗伊斯持仓
明星投资者查克·罗伊斯持仓,最新持仓市值1.18K

分析师目标

根据 4 位分析师
持有
评级
43.000
目标均价
+6.28%
涨幅空间
数据免责声明:分析师评级与目标价由LSEG提供,仅供参考,不应当作投资建议

Phibro Animal Health Corp新闻

即将为您带来更多新闻,敬请期待。。。

财务指标

每股收益

由于公司未披露,未能获取相关数据

营业总收入

由于公司未披露,未能获取相关数据

Phibro Animal Health Corp简介

Phibro Animal Health Corporation is a global diversified animal health and mineral nutrition company. It develops, manufactures and markets a range of products for food and companion animals, including poultry, swine, beef and dairy cattle, aquaculture and dogs. It markets approximately 750 product lines in over 80 countries to approximately 4,200 customers. It has three segments: Animal Health, Mineral Nutrition and Performance Products. Its Animal Health segment develops, manufactures and markets about 280 product lines, including antibacterials, anticoccidials and related products; nutritional specialty products; and vaccines. The Mineral Nutrition segment is comprised of formulations and concentrations of trace minerals such as zinc, manganese, copper, iron and other compounds, with a focus on customers in North America. The Performance Products segment manufactures and markets specialty ingredients for use in the personal care, industrial chemical and chemical catalyst industries.
公司代码PAHC
公司Phibro Animal Health Corp
CEOBendheim (Jack C)
网址https://www.pahc.com/

常见问题

Phibro Animal Health Corp(PAHC)的当前股价是多少?

Phibro Animal Health Corp(PAHC)的当前股价是 40.060。

Phibro Animal Health Corp的股票代码是什么?

Phibro Animal Health Corp的股票代码是PAHC。

Phibro Animal Health Corp股票的52周最高点是多少?

Phibro Animal Health Corp股票的52周最高点是46.420。

Phibro Animal Health Corp股票的52周最低点是多少?

Phibro Animal Health Corp股票的52周最低点是16.160。

Phibro Animal Health Corp的市值是多少?

Phibro Animal Health Corp的市值是1.62B。

Phibro Animal Health Corp的净利润是多少?

Phibro Animal Health Corp的净利润为48.26M。

现在Phibro Animal Health Corp(PAHC)的股票是买入、持有还是卖出?

根据分析师评级,Phibro Animal Health Corp(PAHC)的总体评级为持有,目标价格为43.000。

Phibro Animal Health Corp(PAHC)股票的每股收益(EPS TTM)是多少

Phibro Animal Health Corp(PAHC)股票的每股收益(EPS TTM)是1.673。
KeyAI